Press Releases

October 26, 2012 - CTCA and Nanospectra Biosciences Announce Investigational Study of Using Nanoparticles to Kill Cancer Tumors from the Inside Out

August 8 , 2011 - Nanospectra Biosciences, Inc. Names John Stroh New CEO

February 1, 2011 - Early tests find nanoshell therapy effective against brain cancer, Rice bioengineers., Baylor College of Medicine and Texas Children's physician-scientists zap tumors with light-activated nanoparticles

August 3, 2010 - Nanospectra Awarded $1.3 Million NCI Grant for Brain Tumor Application

June 11, 2010 - Nanospectra Founders Halas and West named Inventors of the Year by State Bar of Texas

January 5, 2009 - Nanospectra Completes Additional $1.5 Million Series A Funding

Nanospectra Licenses Tumor Imaging Technology from University of Texas at Austin

November 3, 2008 - Nanospectra Awarded SAIC Contract for Toxicity Studies of Gold Nanorods

September 15, 2008 - Nanospectra Awarded NCI SBIR Phase I for Ablation of Circulation Tumor Cells

July 1, 2008 - Nanospectra Receives FDA Approval of IDE for Head and Neck Cancer Pilot Study